| Original language | English |
|---|---|
| Pages (from-to) | 919-921 |
| Number of pages | 3 |
| Journal | Clinical Chemistry |
| Volume | 57 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2011 |
Primer sequence disclosure: A clarification of the MIQE guidelines
- Stephen A. Bustin
- , Vladimir Benes
- , Jeremy A. Garson
- , Jan Hellemans
- , Jim Huggett
- , Mikael Kubista
- , Reinhold Mueller
- , Tania Nolan
- , Michael W. Pfaffl
- , Gregory L. Shipley
- , Jo Vandesompele
- , Carl T. Wittwer
- Barts and The London School of Medicine and Dentistry
- European Molecular Biology Laboratory Heidelberg
- Royal Free and University College Medical School
- Ghent University Hospital
- Biogazelle NV
- LGC Ltd.
- University College London
- TATAA Biocenter
- Institute of Biotechnology of the Academy of Sciences of the Czech Republic
- Sequenom, Inc.
- Sigma-Aldrich
- University of Texas Health Science Center at Houston
- University of Utah School of Medicine
- ARUP Institute for Clinical and Experimental Pathology
Research output: Contribution to journal › Letter › peer-review
66
Scopus
citations